Market Tracker

07/26 4:10am ET

Merck & Co Inc (NYSE:MRK)

58.56
Delayed Data
As of Jul 25
 -0.26 / -0.44%
Today’s Change
45.69
Today|||52-Week Range
60.07
+10.87%
Year-to-Date
7 Key Figures From Gilead Sciences' Q2 Earnings
Jul 25 / MotleyFool.com - Paid Partner Content
Technology Earnings Helping Market to Gain
Jul 20 / GuruFocus News - Paid Partner Content
Merck (MRK) Stock Down, Ebola Vaccine Under 'Accelerated' FDA Review
Jul 25 / TheStreet.com - Paid Partner Content
5 Big Pharma Stocks Struggling to Raise Their Dividends
Jul 19 / MotleyFool.com - Paid Partner Content
Agenus (AGEN): What's Ahead for the Stock in Q2 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
Celgene to partner Jounce in battle against cancerous cells
Jul 19 / FT.com - Paid Partner Content
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
3 Primary Ways Researchers Are Combatting Cancer
Jul 16 / MotleyFool.com - Paid Partner Content
T. Rowe Price Equity Income Fund Sells Apache, Johnson & Johnson in 2nd Quarter
Jul 21 / GuruFocus News - Paid Partner Content
Gilead's HCV Drug Epclusa Gets Regulatory Nod in Canada
Jul 15 / Zacks.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
Is Advaxis' Stock Now a Bargain?
Jul 15 / MotleyFool.com - Paid Partner Content
Here's Why Myriad Genetics Is Down 26% in 2016
Jul 21 / MotleyFool.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
These 5 Healthcare Stocks Have Huge Dividend Yields -- Are Any Worth Buying?
Jul 21 / MotleyFool.com - Paid Partner Content